Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 23 / 71

0.6 %The median estimated 5-year CVD risk using the DAD equation was 0.6%.

Camerounmaladies cardiovasculairespublished 2017Tropical diseases, travel medicine and vaccineseurope_pmcdocument of 8 observations

10.4 %Pretreatment HIV drug resistance (PDR) prevalence among ART initiators with no prior exposure to antiretrovirals in Cameroon was 10.4% (95% CI 4.7%–21.5%).

CamerounVIH/sidaobserved 2015published 2018The Journal of antimicrobial chemotherapyeurope_pmcdocument of 12 observationsDOI 10.1093/jac/dky221

73.6 %Among 458 patients who initiated antiretroviral therapy in rural district hospitals in Cameroon between 2006 and 2008, 337 (73.6%) were classified at WHO clinical stage 3.

CamerounVIH/sidaobserved 2006-2008published 2010Tropical medicine & international health : TM & IHeurope_pmcdocument of 7 observations

5.9 %The age-standardized prevalence of hypertension was 5.9% in rural women in Cameroon.

Camerounhypertension artériellepublished 1998International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/27.2.181

-0.4 SMDHIV infection was associated with lower systolic blood pressure with a standardized mean difference of -0.40.

Camerounsystolic blood pressure · VIH/sidapublished 2013International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/dyt198

15 %The percentage of the diabetic population who had ever been counselled to lose weight had a median of 15%.

Cameroundiabète (non précisé)observed 2005-15published 2016The lancet. Diabetes & endocrinologyeurope_pmcdocument of 10 observations

2,407 patientsIn Mali, Cameroon, and Ivory Coast, 2407 sickle cell disease patients aged 3 years old and over were included in the study.

Cameroun · Côte d'Ivoire · Malidrépanocytosepublished 2017Bloodeurope_pmcdocument of 4 observationsDOI 10.1182/blood-2016-12-755777

1.16 odds_ratioMean arterial pressure was associated with prevalent diabetes with an odds ratio of 1.16 per standard deviation higher pressure.

Cameroundiabète (non précisé)published 2016Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument of 3 observations

2 sitesSIVgor antibody-positive samples were identified at 2 sites in Cameroon.

CamerounSIVgorpublished 2009Journal of VirologyOpenAlexdocument of 4 observationsDOI 10.1128/jvi.02129-09

46.7 %Among those without ketotic-phase ketosis-prone diabetes, 46.7% were positive for HHV8 antibodies.

CamerounHHV8 · ketosis-prone diabetespublished 2018Journal of diabeteseurope_pmcdocument of 10 observations

90.8 %Among 76 patients followed-up at endpoint, 90.8% had viremia <1000 copies/ml.

CamerounVIH/sidaobserved 2009-2011published 2013PLoS ONEOpenAlexdocument of 8 observationsDOI 10.1371/journal.pone.0072680

39 %Le paludisme est responsable de 39 % des cas chez les femmes enceintes au Cameroun selon les rapports d’activités du PNLP de 2006.

Camerounpaludismeobserved 2006HAL · Unilimdocument of 98 observations

8.6 %The rate of HCV coinfection among HIV-infected subjects in the study was 8.6%.

CamerounHCV coinfection · VIH/sidaobserved 2001published 2007Emerging infectious diseasesOpenAlexdocument of 7 observationsDOI 10.3201/eid1303.061069

1,411 kcal/dayResting energy expenditure adjusted for total body mass was 1411 [1368-1613] in obese PCOS subjects, 1274 [1174-1355] in nonobese PCOS subjects, and 1239 [1195-1454] in healthy subjects.

Camerounpaludisme compliqué ou sévèrepublished 2016International journal of endocrinologyeurope_pmcdocument of 2 observations

60.4 %The prevalence of metabolic syndrome was 60.4% according to the National Cholesterol Education Programme Adult Treatment Panel III criteria in a group of Cameroonians with type 2 diabetes.

Cameroundiabète de type 2 · syndrome métaboliquepublished 2012Diabetology & metabolic syndromeeurope_pmcdocument of 4 observationsDOI 10.1186/1758-5996-4-22

2.2 %Le paludisme est responsable de 2,2 % de la mortalité dans la population générale au Cameroun selon une enquête du PNLP réalisée en 2004.

Camerounpaludismeobserved 2004HAL · Unilimdocument of 98 observations

35.4 %The age-standardized awareness rate for diabetes alone was 35.4% among men in a semi-urban population in Bafoussam, Cameroon.

Cameroundiabète (non précisé)observed 2012published 2014BMC public healtheurope_pmcdocument of 24 observationsDOI 10.1186/1471-2458-14-696

19.5 %Using body mass index, the prevalence of obesity among women in urban Cameroon was 19.5%.

Camerounobésitépublished 2006BMC public healtheurope_pmcdocument of 6 observations

3.54 hazard_ratioIn age- and sex-adjusted Cox models, metabolic syndrome was associated with hazard ratio (95% CI) of 3.54 (1.00–12.56) for cardiovascular mortality 5 years after stroke onset.

CamerounAVC · maladies cardiovasculaires · syndrome métaboliquepublished 2013PloS oneeurope_pmcdocument of 6 observations

75.5 %The age-standardized treatment rate for diabetes alone was 75.5% among women in a semi-urban population in Bafoussam, Cameroon.

Cameroundiabète (non précisé)observed 2012published 2014BMC public healtheurope_pmcdocument of 24 observationsDOI 10.1186/1471-2458-14-696

5.7 %In Cameroon, the case fatality ratio for mpox was 5.7%.

CamerounmpoxAfrica CDCdocument of 22 observations

10.5 %Over 10.5% of the world's adult population had diabetes in 2021.

Cameroundiabète (non précisé)observed 2021published 2022Diabetes research and clinical practiceeurope_pmcdocument of 7 observationsDOI 10.1016/j.diabres.2021.109119

26 %Overall, 26% of hepatitis B seropositive patients had an HBV DNA level greater than 40 IU/ml.

Camerounhépatite Bobserved 2006-2007published 2012Antiviral therapyeurope_pmcdocument of 4 observations

44 %Training decreased abdominal fat by 44% in middle-aged men with type 2 diabetes.

Cameroundiabète de type 2published 2003European journal of endocrinologyeurope_pmcdocument of 3 observationsDOI 10.1530/eje.0.1490421

31.4 %Hypertension prevalence among urban dwellers in Cameroon was 31.4% [95% CI 27.3–35.5].

Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.